Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Madison Square Garden Entertainment Corp is an entertainment business based in the US. Madison Square Garden Entertainment shares (MSGE) are listed on the NYSE and all prices are listed in US Dollars. Madison Square Garden Entertainment employs 2,400 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $53.12 |
|---|---|
| 52-week range | $50.20 - $85.60 |
| 50-day moving average | $63.91 |
| 200-day moving average | $71.24 |
| Wall St. target price | $83.17 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-16.32 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $53.12 from 2022-07-01
| 1 week (2022-06-27) | 0.36% |
|---|---|
| 1 month (2022-06-03) | -20.00% |
| 3 months (2022-04-04) | -36.03% |
| 6 months (2022-01-04) | -27.98% |
| 1 year (2021-07-02) | -36.36% |
|---|---|
| 2 years (2020-07-02) | -27.08% |
| 3 years (2019-06-30) | N/A |
| 5 years (2017-06-30) | N/A |
| Revenue TTM | $897.9 million |
|---|---|
| Gross profit TTM | $41.4 million |
| Return on assets TTM | -4.38% |
| Return on equity TTM | -16.16% |
| Profit margin | -44.18% |
| Book value | $61.59 |
| Market capitalisation | $1.8 billion |
TTM: trailing 12 months
We're not expecting Madison Square Garden Entertainment to pay a dividend over the next 12 months.
Over the last 12 months, Madison Square Garden Entertainment's shares have ranged in value from as little as $50.2 up to $85.6. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Madison Square Garden Entertainment's is 1.0649. This would suggest that Madison Square Garden Entertainment's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Madison Square Garden Entertainment Corp. engages in the entertainment business. It produces, presents, or hosts various live entertainment events, including concerts, family shows, and special events, as well as sporting events, such as professional boxing, college basketball and hockey, professional bull riding, mixed martial arts, and esports and wrestling in its venues, including Madison Square Garden, Hulu Theater at Madison Square Garden, Radio City Music Hall and Beacon Theatre, and The Chicago Theatre. The company also operates 61 entertainment dining and nightlife venues spanning 23 markets across five continents under the Tao, Marquee, Lavo, Beauty & Essex, Cathédrale, Hakkasan, and Omnia brand names; and creates and operates New England's premier music festival. In addition, it features the Radio City Rockettes, which serves as the star for its Christmas Spectacular at Radio City Music Hall. The company was founded in 2006 and is based in New York, New York. .
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.